Product NDC: | 42195-308 |
Proprietary Name: | Nalfon |
Non Proprietary Name: | fenoprofen calcium |
Active Ingredient(s): | 400 mg/1 & nbsp; fenoprofen calcium |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42195-308 |
Labeler Name: | Xspire Pharma |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017604 |
Marketing Category: | NDA |
Start Marketing Date: | 20120827 |
Package NDC: | 42195-308-50 |
Package Description: | 500 CAPSULE in 1 BOTTLE (42195-308-50) |
NDC Code | 42195-308-50 |
Proprietary Name | Nalfon |
Package Description | 500 CAPSULE in 1 BOTTLE (42195-308-50) |
Product NDC | 42195-308 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fenoprofen calcium |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120827 |
Marketing Category Name | NDA |
Labeler Name | Xspire Pharma |
Substance Name | FENOPROFEN CALCIUM |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |